Literature DB >> 26553512

Therapy: PHD inhibitors correct anaemia in CKD.

Ellen F Carney.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26553512     DOI： 10.1038/nrneph.2015.184

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  2 in total

1.  Four-Week Studies of Oral Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor GSK1278863 for Treatment of Anemia.

Authors:  Louis Holdstock; Amy M Meadowcroft; Rayma Maier; Brendan M Johnson; Delyth Jones; Anjay Rastogi; Steven Zeig; John J Lepore; Alexander R Cobitz
Journal:  J Am Soc Nephrol       Date:  2015-10-22       Impact factor: 10.121

2.  Roxadustat (FG-4592): Correction of Anemia in Incident Dialysis Patients.

Authors:  Anatole Besarab; Elena Chernyavskaya; Igor Motylev; Evgeny Shutov; Lalathaksha M Kumbar; Konstantin Gurevich; Daniel Tak Mao Chan; Robert Leong; Lona Poole; Ming Zhong; Khalil G Saikali; Marietta Franco; Stefan Hemmerich; Kin-Hung Peony Yu; Thomas B Neff
Journal:  J Am Soc Nephrol       Date:  2015-10-22       Impact factor: 10.121
  2 in total
  1 in total

1.  Zinc Inhibits HIF-Prolyl Hydroxylase Inhibitor-Aggravated VSMC Calcification Induced by High Phosphate.

Authors:  Annamária Nagy; Dávid Pethő; Tamás Gáll; Erzsébet Zavaczki; Mónika Nyitrai; József Posta; Abolfazl Zarjou; Anupam Agarwal; György Balla; József Balla
Journal:  Front Physiol       Date:  2020-01-15       Impact factor: 4.566
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.